Co-prescription of antidepressants with other psychotropics: Distinct profile of escitalopram

International Journal of Psychiatry in Clinical Practice

Volumn 12, Issue 1, 2008, Pages 31-35

  Barak, Yoram ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b ABARBANEL MENTAL HEALTH CENTER   (Israel)

Author keywords

Antidepressants; Epidemilogy; Escitalopram; Polypharmacy; SSRI

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; CLOMIPRAMINE; DESIPRAMINE; DIBENZEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOOD STABILIZER; PSYCHOTROPIC AGENT; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; HUMAN; ISRAEL; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 45849083080     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500701419701     Document Type: Article

References (23)

1. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005;143:415-26.
2. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev 2000;CD001851.
3. Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001;57:161-78.
4. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. J Am Med Assoc 2002;287:203-9.
5. Guaiana G, Andretta M, Corbari L, et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 2005;66:750-5.
6. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005;62:165-72.
7. Barak Y, Aizenberg D. The association between antidepressant prescribing and suicide in Israel. Int Clin Psychopharmacol 2006;21:281-4.
8. Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005;14:121-8.
9. Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9-15.
10. Kotzan JA, Maclean R, Wade W, et al. Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clin Ther 2002;24:237-48.
11. Rubinow DR. Treatment strategies after SSRI failure - Good news and bad news. New Engl J Med 2006;354:1305-7.
12. IMS Retail Drug Monitor, IMS Health Incorporated; 2004.
13. SAS/STAT Users' Guide, Version 8, vols 1,2. Cary, NC: SAS Institute; 1994.
14. Barbui C, Broglio E, Laia AC, et al. Cross-sectional database analysis of antidepressant prescribing in Italy. J Clin Psychopharmacol 2003;23:31-4.
15. McCue RE, Waheed R, Urcuyo L. Polypharmacy in patients with schizophrenia. J Clin Psychiatry 2003;64:984-9.
16. Linne AB, Liedholm H. Audit of prescribing practices in nursing homes. Many preparations but few serious interactions. Lakartidningen 2003;10:2360-5.
17. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999;19:132-4.
18. de las Cuevas C, Sanz EJ, de la Fuente JA, Cueto M. Polypharmacy in psychiatric patients as an alternative to limited mental health Resources. Actas Esp Psiquiatr 2005;33:81-6.
19. Silkey B, Preskorn SH, Golbeck A, et al. Complexity of medication use in the Veterans Affairs healthcare system: Part II. Antidepressant use among younger and older outpatients. J Psychiatr Pract 2005;11:16-26.
20. Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 2004;49:303-9.
21. van Dijk KN, de Vries CS, ter Huurne K, van den Berg PB, Brouwers JR, de Jong-van den Berg LT. Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly. J Clin Epidemiol 2002;55:1049-3.
22. Stahl SM. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. CNS Spectr 2005;10:319-23.
23. Simon J, Pilling S, Burbeck R, Goldberg D. Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline. Br J Psychiatry 2006;189:494-501.